Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats

Hypertension Research

Volumn 31, Issue 7, 2008, Pages 1455-1464

  Yatabe, Junichi ^a   Sanada, Hirobonu ^a   Midorikawa, Sanae ^a   Hashimoto, Shigeatsu ^a   Watanabe, Tsuyoshi ^a   Andrews, Peter M ^b   Armando, Ines ^b   Wang, Xiaoyan ^b   Felder, Robin A ^c   Jose, Pedro A ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Blood pressure; G protein coupled receptor kinase 4; Hypertension; Kidney; Receptors

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANTISENSE OLIGODEOXYNUCLEOTIDE; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 4; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ANALYSIS; ENZYME LOCALIZATION; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY CORTEX; KIDNEY FUNCTION; MALE; NATRIURESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEINURIA; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; KIDNEY CORTEX; MALE; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHORYLATION; POTASSIUM; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE D1; RENIN; RNA, MESSENGER; SODIUM;

EID: 55449106820     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.1455     Document Type: Article

References (42)

1. Felder RA, Jose PA: The role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol 2006; 2: 637-650.
2. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA: Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004; 19: 233-246.
3. Hussain T, Lokhandwala MF: Renal dopamine receptors and hypertension. Exp Biol Med 2003; 228: 134-142.
4. Lavoie JL, Sigmund CD: Minireview: overview of the renin-angiotensin system - an endocrine and paracrine system. Endocrinology 2003; 144: 2179-2183.
5. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H: Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39: 316-322.
6. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI: Counterregulatory actions of angiotensin-(1-7). Hypertension 1997; 30: 535-541.
7. Crowley SD, Gurley SB, Oliverio MI, et al: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005; 115: 1092-1099.
8. Yoneda M, Sanada H, Yatabe J, et al: Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Hypertension 2005; 46: 58-65.
9. Shigetomi S, Ueno S, Kohno H, et al: Role of renal dopamine receptor in the pathogenesis of hypertension after sodium loading. Nippon Naibunpi Gakkai Zasshi 1986; 62: 26-33.
10. Luippold G, Zimmermann C, Mai M, et al: Dopamine D3 receptors and salt-dependent hypertension. J Am Soc Nephrol 2001; 12: 2272-2279.
11. Haney M, Ward AS, Foltin RW, Fischman MW: Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) 2001; 155: 330-337.
12. Bek MJ, Wang X, Asico LD, et al: Angiotensin-II type 1 receptor.mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension 2006; 47: 288-295.
13. Sanada H, Yatabe J, Midorikawa S, et al: Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension 2006; 47: 1131-1139.
14. Felder RA, Sanada H, Xu J, et al: G protein.coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A 2002; 99: 3872-3877.
15. Zhu H, Lu Y, Wang X, Treiber FA, et al: The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am J Hypertens 2006; 19: 61-66.
16. Zhu H, Lu Y, Wang X, et al: The G protein-coupled receptor kinase 4 gene modulates stress-induced sodium excretion in black normotensive adolescents. Pediatr Res 2006; 60: 440-442.
17. Speirs HJ, Katyk K, Kumar NN, et al: Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004; 22: 931-936.
18. Gu D, Su S, Ge D, et al: Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension 2006; 47: 1147-1154.
19. Williams SM, Ritchie MD, Phillips JA 3rd, et al: Multilocus analysis of hypertension: a hierarchical approach. Hum Hered 2004; 57: 28-38.
20. Sanada H, Yatabe J, Midorikawa S, et al: Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem 2006; 52: 352-360.
21. Zeng C, Luo Y, Asico LD, et al: Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension 2003; 42: 787-792.
22. Zeng C, Yang Z, Wang Z, et al: Interaction of AT1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 2005; 45: 804-810.
23. Yu P, Asico LD, Luo Y, et al: D1 dopamine receptor hyper-phosphorylation in renal proximal tubules in hypertension. Kidney Int 2006; 70: 1072-1079.
24. Wang ZQ, Felder RA, Carey RM: Selective inhibition of the renal dopamine subtype D1A receptor induces antinatriuresis in conscious rats. Hypertension 1999; 33: 504-510.
25. Rankin ML, Marinec PS, Cabrera DM, et al: The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol 2006; 69: 759-769.
26. Iacovelli L, Salvatore L, Capobianco L, et al: Role of G protein-coupled receptor kinase 4 and β-arrestin 1 in agonist-stimulated metabotropic glutamate receptor 1 internalization and activation of mitogen-activated protein kinases. J Biol Chem 2003; 278: 12433-12442.
27. Pi M, Oakley RH, Gesty-Palmer D, et al: Beta-arrestin- and G protein receptor kinase-mediated calcium-sensing receptor desensitization. Mol Endocrinol 2005; 19: 1078-1087.
28. Perroy J, Adam L, Qanbar R, Chenier S, Bouvier M: Phosphorylation-independent desensitization of GABAB receptor by GRK4. EMBO J 2003; 22: 3816-3824.
29. Oppermann M, Diverse-Pierluissi M, Drazner MH, et al: Monoclonal antibodies reveal receptor specificity among G-protein. coupled receptor kinases. Proc Natl Acad Sci U S A 1996; 93: 7649-7654.
30. Premont RT, Macrae AD, Stoffel RH, et al: Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem 1996; 271: 6403-6410.
31. Virlon B, Firsov D, Cheval L, et al: Rat G protein-coupled receptor kinase GRK4: identification, functional expression, and differential tissue distribution of two splice variants. Endocrinology 1998; 139: 2784-2789.
32. Wang Z, Asico LD, Escano CS, et al: Human G protein-coupled receptor kinase type 4γ (hGRK4γ) wild-type prevents salt sensitivity while its variant, hGRK4γ496V, promotes salt sensitivity in transgenic mice: role of genetic background. Hypertension 2006; 48: e27.
33. Yamaguchi I, Yao L, Sanada H, et al: Dopamine D1A receptors and renin release in rat juxtaglomerular cells. Hypertension 1997; 29: 962-968.
34. Veerasingham SJ, Sellers KW, Raizada MK: Functional genomics as an emerging strategy for the investigation of central mechanisms in experimental hypertension. Prog Biophys Mol Biol 2004; 84: 107-123.
35. DiBona GF: Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 2002; 11: 197-200.
36. Yai B, Fan X, Harris RC, Zhang MZ: Dopamine stimulation of renin expression is only seen when renal COX-2 activity is inhibited. J Am Soc Nephrol 2007; 18: 163A.
37. Sanada H, Yao L, Jose PA, Carey RM, Felder RA: Dopamine D3 receptors in rat juxtaglomerular cells. Clin Exp Hypertens 1997; 19: 93-105.
38. Williams BC, Eglen A, Duncan FM, Edwards CR: The effect of sodium intake on the renin response to dopamine in superfused rat renal cortical cells. J Hypertens 1985; 3 (Suppl 3): S267-S268.
39. Persson AE, Ollerstam A, Liu R, Brown R: Mechanisms for macula densa cell release of renin. Acta Physiol Scand 2004; 181: 471-474.
40. Mervaala E, Muller DN, Schmidt F, et al: Blood pressure-independent effects in rats with human renin and angiotensinogen genes. Hypertension 2000; 35: 587-594.
41. Parving HH, Lehnert H, Bröchner-Mortensen J, et al, Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345: 870-878.
42. Panos J, Michelis MF, DeVita MV, Lavie RH, Wilkes BM: Combined converting enzyme inhibition and angiotensin receptor blockade reduce proteinuria greater than converting enzyme inhibition alone: insights into mechanism. Clin Nephrol 2003; 60: 13-21.